Page 170 - IJB-10-6
P. 170

International Journal of Bioprinting                                3D bioprinting technology for brain tumor



















































            Figure 4. Construction and microscopic images of glioblastoma (GBM)-on-a-chip. (A) The microfluidic chip used in the GBM-on-a-chip contains
            chambers that control the flow of nutrients, oxygen, and culture media, which are necessary for reproducing the in vivo tumor environment. The bioink
            includes GBM cells and extracellular matrix components, deposited into the microfluidic chip using a 3D bioprinter. This system leads to the creation of
            intricate tumor structures within the chip. The integration of vasculature and tumor-associated stroma closely resembles the interaction between the tumor
            and surrounding tissues in the brain. (B) Representative phase-contrast optical image (left) and fluorescence microscopy image (right) of bioprinted GBM-
            on-a-chip cells distinguish between glioblastoma cells (red) and endothelial cells (green). Adapted with permission from ref. 105


             6
            O BG suppressed the GBM-on-chips most effectively. In   microfluidic network, was fabricated by casting it in a
            addition, the combination of cisplatin, KU60019 (a specific   photolithographically created mold 117,118  (Figure 5). An
            ATM kinase inhibitor for cancer combination therapy),    open tissue compartment composed of concentrated
                                                         115
            and O BG with radiation was notably effective on GBM-  GBM  cells  and  surrounding  brain  endothelial  cells  was
                 6
            28-on-a-chip. In contrast, GBM-37-on-a-chip exhibited   created to enable direct 3D bioprinting of the tumor
                                                                       119
            high resistance to the drugs involved in the DNA repair   construct.  The outer channels were designed for media
            response,  suggesting that the ex vivo GBM model has the   perfusion, drug testing, and the introduction of other cell
                   105
            potential to identify optimal treatments.          types, including astrocytes, to mimic a heterogeneous
                                                               brain tumor environment. 116,9  The vascularized GBM-
            5.3. Vascularized GBM-on-a-chip                    on-a-chip can represent the synergy of microfluidics and
            A 3D microfluidic bioprinting model of a vascularized   bioprinting by simultaneously recapitulating the significant
            GBM-on-a-chip growing as a dense sphere revealed   physiological functions of in vivo GBMs, offering a more
            morphologically distinct regions within the brain   biomimetic and realistic strategy to simulate GBM tumors
            TME.  Polydimethylsiloxane, based on a customized   with flexibility. 120–123
                116


            Volume 10 Issue 6 (2024)                       162                                doi: 10.36922/ijb.4166
   165   166   167   168   169   170   171   172   173   174   175